Not to my knowledge, but from a cGMP/QSR perspective there could be other implications that need to be considered like sterilisation, cleanliness, individual packages, modifying packaging, etc. There may also be considerations if a prescription device is being packaged with a non-prescription device, but this also depends on how it is being packaged and sold. The question is fairly general, so a general answer, but there could be other implications based on the device types.
------------------------------
Richard Vincins RAC
Vice President Global Regulatory Affairs
------------------------------
Original Message:
Sent: 20-Feb-2019 16:51
From: Anonymous Member
Subject: Packaging an FDA Class I Exempt with a Class II 510k Device
This message was posted by a user wishing to remain anonymous
Is there a regulatory issue with packaging an FDA Class I Exempt device with an existing, cleared Class II device?
Thanks.